• HR-LCMS/MS Reveals a New Glabrol Source

  2026-09-05

  This study presents a streamlined HR-LCMS/MS-based dereplication workflow that connects autophagy activity in plant fractions with candidate bioactive metabolites. By screening medicinal plants in SH-SY5Y cells, the authors identified Astragalus dasyanthus as a previously unrecognized producer of the autophagy-inducing compound glabrol.

• Telatinib (BAY 57-9352) Assay Guide

  2026-09-04

  A scenario-based guide to using Telatinib (BAY 57-9352), SKU A8550, in viability, proliferation, cytotoxicity, invasion, and angiogenesis workflows. It connects reported kinase potency with practical DMSO handling, dose design, phenotype interpretation, combination testing, and product-selection criteria.

• Sunitinib: A Resistance-Aware Assay Guide

  2026-09-04

  Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with applications extending from angiogenesis studies to resistance biology. This guide translates TRIB3–SLC7A11/GPX4 findings into practical assay design for renal cell carcinoma and related tumor models.

• ATRX Loss Sensitizes Glioma to RTK Inhibitors

  2026-09-03

  The reference study identifies ATRX deficiency as a potential biomarker of increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data with temozolomide support genotype-aware treatment evaluation, while also highlighting the need to distinguish cellular drug sensitivity from clinical efficacy.

• (S)-Mephenytoin in Organoid PK Assays

  2026-09-03

  Explore how (S)-Mephenytoin can qualify CYP2C19 activity in hiPSC-derived intestinal organoids. This article presents an assay-design framework that separates enzyme turnover from transport, maturation, and barrier effects.

• GZMK+ CD8+ T Cells Drive Recurrent Airway Inflammation

  2026-09-02

  The reference study identifies persistent GZMK-expressing CD8+ effector-memory T cell clones as a cellular basis for recurrent nasal polyps and related airway inflammation. By linking T cell clonality to GZMK-dependent complement cleavage, human tissue biomarkers, and intervention in a mouse asthma model, the work provides a mechanistic framework for studying inflammatory disease recurrence.

• MRT68921 ULK1 Kinase Inhibitor Workflow

  2026-09-02

  MRT68921 enables controlled blockade of autophagy initiation, making it useful for separating ULK-dependent effects from rapamycin-driven responses in lipid-stressed cells. This workflow connects ATG13 phosphorylation, LC3 flux measurement, lipidomics, and proteomics to practical assay decisions.

• Hydrocortisone Beyond the Bench: Designing Translation

  2026-09-01

  Hydrocortisone is more than a reference glucocorticoid hormone: it is a mechanistic probe and a translational design variable. This article connects receptor biology, inflammation and neuroprotection models, and PLGA-based corticosteroid delivery to help researchers build more predictive development strategies.

• AY 9944: From Sterol Control to Antiviral Insight

  2026-09-01

  DHCR7 is emerging as more than a cholesterol-biosynthesis enzyme. This thought-leadership guide connects AY 9944 dihydrochloride-based sterol perturbation with genetic evidence from GCRV-resistant grass carp, while outlining how translational researchers can separate validated biology from experimental opportunity.

• ATRX Loss Rewires RTK Inhibitor Sensitivity

  2026-08-31

  The reference study identifies ATRX deficiency as a potential determinant of sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data further support evaluating ATRX status when studying RTK inhibitor and temozolomide treatment strategies, while highlighting the need for genotype-aware interpretation of clinical trials.

• Pazopanib Hydrochloride: In Vitro Workflow

  2026-08-31

  Build more informative Pazopanib Hydrochloride experiments by separating growth inhibition from actual cell killing. This workflow combines dose-response design, time-resolved viability measurements, and angiogenesis-relevant assays to improve interpretation in cancer research.

• Cy5-UTP: Designing Better Fluorescent RNA Assays

  2026-08-30

  Cy5-UTP enables direct, far-red visualization of RNA generated by in vitro transcription. This guide connects Cyanine 5-uridine triphosphate chemistry with assay design for FISH, expression arrays, and RNA phase-separation studies.

• Cell Senescence β-Galactosidase Staining Kit Guide

  2026-08-29

  Build a practical SA-β-Gal workflow for fibroblast senescence models, senolytic screening, and frozen tissue analysis. This guide pairs the Cell Senescence β-Galactosidase Staining Kit with appropriate controls, quantitative scoring, and troubleshooting strategies for more reproducible senescent cell detection.

• Cinoxacin Workflows for Gram-Negative Research

  2026-08-28

  Cinoxacin is a quinolone antibiotic for structured susceptibility testing, urinary tract infection research, and Gram-negative pathogen profiling. This guide connects its concentration range, formulation limits, and organism selectivity to reproducible workflows, resistance experiments, and practical troubleshooting.

• Sulfo-Cy3 Azide for Aqueous Bioconjugation

  2026-08-28

  Sulfo-Cy3 azide is a water-soluble bioconjugation reagent for Click Chemistry fluorescent labeling of alkyne-bearing biomolecules. Its sulfonated structure supports aqueous workflows, while reported optical specifications include 563 nm excitation, 584 nm emission, and an extinction coefficient of 162,000 M⁻¹cm⁻¹.

8355 records 2/557 page Previous Next 12345 下5页 Last page